Hernia, Ventral, Rectus Diastasis
Conditions
Keywords
eTEP, Retromuscular, Minimally invasive, Endoscopic, Hernia, Rectus diastasis, Rives-Stoppa
Brief summary
Observational cohort study (partially retrospective, partially prospective) comparing the endoscopic extended totally extraperitoneal prosthesis (eTEP) repair for midline abdominal hernias to open Rives-Stoppa repair (control).
Detailed description
See included study protocol. Included patients will be registered to the European Hernia Society (EHS) registry.
Interventions
PROCEDUREEndoscopic eTEP
Endoscopic extended view totally extraperitoneal prosthesis repair.
PROCEDUREOpen Rives-Stoppa
Open Rives-Stoppa repair with retromuscular mesh placement.
Sponsors
AZ Alma
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
Group 1 (eTEP): * Participants who underwent an eTEP procedure in the investigators' center * Preoperative existence of one or more midline abdominal wall hernias * Preoperative existence of rectus abdominis diastasis Group 2 (Rives-Stoppa, control group): \- Participants who underwent an open Rives-Stoppa (midline repair with sublay mesh) in the investigators' center
Exclusion criteria
Group 1 (eTEP): * Preoperative absence of midline abdominal wall hernias * Preoperative absence of rectus abdominis diastasis * Intraoperative performance of transverse abdominis release (TAR) * Intraoperative inguinal hernia repair Group 2 (Rives-Stoppa, control group): * Intraoperative performance of transverse abdominis release (TAR) * Intraoperative performance of anterior component separation * Intraoperative inguinal hernia repair
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Length of hospital stay | From the date of operation until the date of discharge from the hospital, assessed up to 30 days. | Time (days) spent within the hospital |
| Postoperative pain management | From the end of surgery (moment of the end of operation) until the date of discharge from the hospital, assessed up to 30 days. | Modality (type, generic name), duration (days), dosage (grams or milligrams) and frequency (times per day) of analgesics administration |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative complications | After discharge until 30 days postoperative | Adverse event occurrence by readmission |
| Intraoperative complications | During surgery | Adverse event occurrence |
Countries
Belgium
Outcome results
None listed